News
Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC’s Advisory Committee on Immunization Practices on ...
Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...
Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...
16h
Asianet Newsable on MSNMerck Gets FDA Approval For Keytruda To Treat A Broader Population Of Head And Neck Cancer Patients: Retail Stays BullishIn the U.S., it is estimated there will be approximately 72,680 new cases of head and neck cancer diagnosed and more than ...
Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat ...
Given that the Australian government heavily subsidizes pharmaceuticals— spending more than $AU16.7 billion annually through ...
Explore more
Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert ...
Merck & Co. Inc. closed 39.23% short of its 52-week high of $134.63, which the company reached on June 25th.
One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...
Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...
Merck & Co., Inc. (NYSE:MRK) is one of the best Dow stocks to invest in. On June 9, the company announced that its drug, ...
The stock's fall snapped a three-day winning streak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results